BX
Blackstone Inc.
BX has a slight edge over MS overall, supported by stronger valuation.
MS
Morgan Stanley
MS has slightly lower modeled downside risk, despite its lower overall score.
BX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BX.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $77.47 | -35% |
| Forward | 18x | $119 | — |
| Current | 26x | $119 | — |
| Fair | 34x | $151 | +27% |
| Expensive | 58x | $259 | +118% |
Historical ranges are pointers, not guarantees.
BX has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BX, with profitability holding steady. However, they disagree widely on these estimates.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BX on the outlook, with more favorable profitability expectations.
BX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.61 | +47% |
| Q3 2026 | $4.49 | +29% |
| Q2 2026 | $4.46 | +20% |
| Q1 2026 | $3.90 | +18% |
| Q4 2025 | $3.87 | +6.9% |
| Q3 2025 | $3.49 | +20% |
| Q2 2025 | $3.71 | +41% |
| Q1 2025 | $3.31 | +17% |
| Q4 2024 | $3.62 | +97% |
BX's earnings per share have fallen from their peak: $4.49 over the past year, against $8.13 in late 2021.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BX on earnings, with stronger typical year-over-year growth.
BX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -0.8% |
| Q2 2026 | $5B | +36% |
| Q1 2026 | $3.6B | +10% |
| Q4 2025 | $4.4B | +41% |
| Q3 2025 | $3.1B | -16% |
| Q2 2025 | $3.7B | +33% |
| Q1 2025 | $3.3B | -11% |
| Q4 2024 | $3.1B | +140% |
BX's revenue is growing: $3.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +3.6 points |
| Q2 2026 | 53% | +5 points |
| Q1 2026 | 37% | -4.9 points |
| Q4 2025 | 51% | -0.1 points |
| Q3 2025 | 43% | -4.9 points |
| Q2 2025 | 48% | +6.3 points |
| Q1 2025 | 42% | -9 points |
| Q4 2024 | 51% | +25 points |
BX has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +22% |
| Q2 2026 | $1.9B | +125% |
| Q1 2026 | $957.6M | -11% |
| Q4 2025 | $1B | +599% |
| Q3 2025 | $1.6B | +31% |
| Q1 2025 | $1.1B | +17% |
| Q4 2024 | $149.5M | -83% |
| Q3 2024 | $1.2B | +18% |
BX has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +82.9K shares |
| 1 year | +2.2% | +17.3M shares |
| 3 years | +5.5% | +41.9M shares |
| 5 years | +11% | +77.5M shares |
| Available history | +18% | +124M shares |
BX has 800M diluted shares, up 2.2% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BX on shareholder dilution, with a more favorable share count trend.
BX Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 29.9 | Neutral |
BX's weekly RSI is 45 (neutral) and its Stochastic is 30 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BX PE vs Financial Services Sector
| Metric | BX | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 103% above |
| PE % | 35 | 63 | 28 pts below |
BX is trading at 26x earnings, a 103% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over BX on valuation relative to its sector.
BX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $115.7 | 2.5% above |
| 20 week MA | $125.6 | 5.6% below |
| 50 week MA | $127.7 | 7.2% below |
| 100 week MA | $142.1 | 17% below |
| 200 week MA | $130.3 | 9% below |
BX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over BX on trend strength, trading above more of its moving averages.
BX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.1 | $65.0 | +16% |
| 2021 | $65.0 | $135.0 | +108% |
| 2022 | $135.0 | $74.9 | -45% |
| 2023 | $74.9 | $130.9 | +75% |
| 2024 | $130.9 | $174.0 | +33% |
| 2025 | $174.0 | $155.4 | -11% |
| 2026 YTD | $155.4 | $118.5 | -24% |
BX's yearly returns have swung widely, from +108% in 2021 to −45% in 2022. It's down 24% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BX on returns for 2026, with the stronger performance.